JPRN-UMIN000009107
Recruiting
未知
A clinical study on safety and efficacy of combined intraarterial cisplatin and 5-fluorouracil with systemic pegylated interferon alfa-2b for advanced hepatocellular carcinoma - A combination therapy of CDDP / 5-FU / PEG-IFN alfa-2b for advanced hepatocellular carcinoma. : study of safety and efficacy
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Iwate Medical University
- Enrollment
- 60
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\.Pregnant or breast\-feeding patients. 2\.Patients with hypersensitivity to Pt\-drug and IFN 3\.Severe complication 4\.Patients with interstitial pneumonia or a history 5\.Patients with central nervous system disorders , the depression or a history 6\.Inappropriate patients for this study judged by physicians.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Clinical trial of efficacy and safety of the combination of reduced duration prophylaxis followed by immuno-guided prophylaxis in lung transplant recipients.EUCTR2018-003300-39-ESFundación para la Investigación Biomédica de Córdoba150
Not yet recruiting
Phase 2
A clinical study to see the combined effect of Pathyadi churna and Kshara basti in the management of Rheumatoid arthritisHealth Condition 1: M069- Rheumatoid arthritis, unspecifiedCTRI/2021/02/031002Sri Dharmasthala College of Ayurveda and Hospital
Completed
Not Applicable
Investigation on efficacy and safety of combination treatment with imidafenacin and mirabegron in patients with overactive bladder.overactive bladderJPRN-UMIN000016236Clinical Research Support Center Kyushu30
Completed
Not Applicable
A clinical study on the usefulness of combination tablet of candesartan and hydrochlorothiazide in hypertensive patientsJPRN-UMIN000005886Division of Kidney and Hypertension, Department of Internal Medicine, Jikei University School of Medicine30
Completed
Phase 4
A clinical evaluation of safety of combination therapy with Rapid Onset Opioid and Short Acting Opioid.Cancer PainJPRN-UMIN000019224Kansai Electric Power Hospital30